← SynDRA
CEVIMELINE
SynDRA canonical compound SYN0005379 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CHRM1 | CHRM3 |
|---|
| Mechanism of action | acetylcholine receptor agonist |
|---|
| Indication | sjogren's syndrome |
|---|
| Disease area | rheumatology |
|---|
All known targets
- CHRM3
- CHRM1
- CHRM2
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- CHRM1 AGONIST
- CHRM2 AGONIST
- CHRM3 AGONIST
- CHRM4 AGONIST
- acetylcholine receptor agonist
Drug classes
- Cholinergic Muscarinic Agonists
- Cholinergic Agents
- Cholinergic Agonists
- Muscarinic Agonists
- Neurotransmitter Agents
- Parasympathomimetics
- Peripheral Nervous System Agents
- Cholinergic Receptor Agonist
ATC classes
Cross-references
Synonyms
- CEVIMELINE HYDROCHLORIDE
- EVOXAC
- Evoxac
- cevimeline hydrochloride hydrate
- cevimeline hydrochloride
- evoxac
- cevimeline HCl
- cevimeline hydrochloride hemihydrate
- Cevimelina
- Saligren
- Cevimeline [INN]
- Cevimeline hydrochloride
- Cevimeline hydrochloride [USAN]
- Cevimeline hydrochloride hemihydrate
- Cevimeline hydrochloride hydrate
- AF-102B
- AF102B
- FKS-508
- Cevimeline (INN)
- Cevimeline HCl 1/2H2O
- Cevimeline hydrochloride (USAN)
- Cevimeline hydrochloride hydrate (JAN)
- Cevimeline.HCl
- Evoxac (TN)
- SND-5008
- SNI-2011
- SNK-508
- Saligren (TN)
- SND 5008, AF-102B, FKS-508
- SCHEMBL299760
- GTPL9658
- WUTYZMFRCNBCHQ-UHFFFAOYSA-N
- BDBM50048353
- EBC-611078
- LS-13854
- CS-0001473
- L001235
- SR-01000944410
Look up CEVIMELINE in the interactive SynDRA portal →